Our Services
Medical Information
Helpful Resources
Published on: 9/13/2026
Hormonal shifts during pregnancy, postpartum, perimenopause, and thyroid changes can trigger muscle twitching, weakness, cramping, fatigue, numbness, and tingling that closely mimic early ALS, though they do not cause ALS itself. Far more common explanations include B12 or iron deficiency, anemia, thyroid disorders, nerve compression such as carpal tunnel, electrolyte imbalances, and autoimmune conditions like myasthenia gravis that can flare with hormonal change. True ALS is rare and tends to present as painless, progressive, asymmetric weakness with visible muscle wasting that does not resolve after delivery or hormonal stabilization. There are several important distinctions between hormone-related symptoms and neurological red flags, and the timing, symmetry, and progression of your symptoms matter a great deal, so see below to understand more.
Because these overlapping causes are difficult to sort out on your own, and because reassurance or early answers both change what you should do next, it is worth taking a few minutes to complete a free, instant, online symptom check to clarify what may be driving your symptoms and which type of care to seek first.
Last reviewed for medical accuracy: 09/12/2026
Can pregnancy or hormone changes cause ALS-like symptoms in women?
Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disease that affects nerve cells controlling voluntary muscles. Its hallmark features include muscle weakness, twitching (fasciculations), stiffness and eventual loss of motor control. Because pregnancy and hormone fluctuations can also impact the nervous system and muscles, it’s natural to wonder whether they might trigger ALS-like symptoms. Here’s what the science and clinical experience tell us:
Understanding ALS
• Definition: ALS (also known as Lou Gehrig’s disease) involves the gradual degeneration of motor neurons in the brain and spinal cord.
• Key symptoms: muscle weakness (often starting in hands or feet), muscle cramps, fasciculations, slurred speech, difficulty swallowing.
• Progression: relentless and irreversible, usually leading to significant disability within 3–5 years of onset.
• Risk factors: mostly unknown; genetics play a role in ~10% of cases. There is no clear link to pregnancy or female hormones in causing true ALS.
How pregnancy and hormones affect nerves and muscles
• Hormonal surges: estrogen and progesterone rise dramatically in pregnancy, then drop after delivery.
• Fluid shifts and weight gain: can put pressure on nerves (e.g., carpal tunnel syndrome in pregnancy).
• Metabolic changes: electrolyte imbalances (low potassium or calcium) can cause cramps or twitching.
• Autoimmune modulation: pregnancy can temporarily suppress or unmask autoimmune conditions.
Common pregnancy-related neuromuscular complaints
Most are benign or self-limited, improving after delivery or with simple treatments:
• Fasciculations (“twitches”)
– Up to 70% of pregnant women report muscle twitching, especially in calves or eyelids.
– Caused by electrolyte shifts, fatigue or mild nerve irritation.
• Muscle cramps
– Often in calves or feet, more common in the third trimester.
– Linked to low magnesium, calcium or potassium.
• Carpal tunnel syndrome
– Wrist/hand numbness and tingling due to fluid retention compressing the median nerve.
– Usually resolves after childbirth.
• Postpartum thyroiditis
– Inflammation of the thyroid gland 2–6 months after delivery.
– Can cause transient hyperthyroid symptoms (weakness, tremor) followed by hypothyroid phase (fatigue, cramps).
• Benign fasciculation syndrome
– Persistent twitching without nerve damage.
– May worsen with stress, fatigue or hormonal shifts.
Conditions that can mimic ALS during or after pregnancy
True ALS is rare in women of childbearing age. However, some treatable disorders can present with similar signs:
• Guillain-Barré syndrome (GBS)
– Autoimmune attack on peripheral nerves; often preceded by infection.
– Rapid weakness that may affect breathing; improves with treatment (IVIG, plasmapheresis).
• Myasthenia gravis
– Autoimmune disorder targeting neuromuscular junction.
– Fluctuating muscle weakness worse with activity; often affects eyes, face, swallowing.
– Can exacerbate during pregnancy or postpartum.
• Multiple sclerosis (MS)
– Autoimmune demyelinating disease of the central nervous system.
– May present with muscle weakness or spasticity; relapses often decrease during pregnancy but rebound postpartum.
• Electrolyte disturbances
– Hypokalemia or hypocalcemia can cause significant muscle weakness and cramps.
– Easily corrected with supplements.
• Thyroid disease
– Both hyper- and hypothyroidism can lead to muscle weakness, cramping or stiffness.
– Diagnosed by blood tests and managed with medication.
• Functional neurological symptom disorder
– Also called “conversion disorder”; neurological symptoms without structural disease.
– Stress or hormonal changes can trigger transient motor or sensory symptoms.
Why pregnancy-related changes are unlikely to cause true ALS
• Disease mechanism: ALS involves motor‐neuron death, not reversible hormonal or fluid-related changes.
• Age of onset: most ALS cases occur between ages 55–75. Onset during childbearing years is extremely rare.
• Progression pattern: pregnancy-related symptoms tend to resolve or improve postpartum, whereas ALS relentlessly worsens.
• Diagnostic tests:
– Electromyography (EMG) and nerve conduction studies can distinguish between motor‐neuron disease and peripheral nerve disorders.
– Blood tests, imaging and spinal fluid analysis help rule out other causes.
When to seek medical evaluation
Although most pregnancy-related neuromuscular symptoms are benign, you should speak with a doctor if you experience:
• Progressive or severe muscle weakness that interferes with daily activities
• Bulbar symptoms: slurred speech, difficulty swallowing or unexplained choking
• Fasciculations accompanied by muscle wasting or significant weakness
• Numbness or tingling that persists or worsens
• Breathing difficulties or rapidly spreading weakness
Before your appointment, you might try a free, online symptom check, using the doctor approved Ubie Symptom Checker to get guidance on possible causes and urgency of evaluation.
What to expect from diagnosis and treatment
If you report concerning neuromuscular symptoms, your healthcare provider may:
• Take a detailed history, including timing, progression and associated symptoms
• Perform a neurological exam: muscle strength, reflexes, coordination, sensation
• Order laboratory tests: thyroid function, electrolytes, autoimmune markers
• Refer for EMG/nerve conduction studies to pinpoint nerve vs. muscle involvement
• Obtain imaging (MRI) if central nervous system disease is suspected
• Guide treatment based on the underlying cause:
– Electrolyte supplementation for cramps
– Anti-inflammatory or immune therapies for autoimmune conditions
– Hormone management for thyroid disease
– Physical therapy to maintain strength and mobility
Managing anxiety around neuromuscular symptoms
It’s natural to worry when you encounter unfamiliar symptoms during pregnancy or postpartum. Keep in mind:
• Benign fasciculations and cramps are very common and often self-limited.
• True ALS is exceedingly rare in young women and has a distinct, progressive pattern.
• Early evaluation of concerning signs helps catch treatable conditions.
• Support groups and counseling can help you cope with uncertainty.
Key take-aways
• Pregnancy and hormonal shifts can cause muscle twitching, cramps and weakness—but these are usually temporary and reversible.
• ALS is a degenerative motor‐neuron disease with a relentless course; it is not triggered by pregnancy or female hormones.
• Several treatable disorders (e.g., thyroid disease, GBS, myasthenia gravis) can mimic ALS.
• If you have progressive weakness, bulbar symptoms or severe neuromuscular complaints, speak to your doctor promptly.
• Consider a free, online symptom check, using the doctor approved Ubie Symptom Checker to help clarify the urgency and possible causes of your symptoms.
Always consult a healthcare professional about any life-threatening or serious symptoms. Early diagnosis and treatment can make a big difference in outcomes.
(References)
* Perry S. ALS. MCN Am J Matern Child Nurs. 2005 Mar-Apr;30(2):141; author reply 141. doi: 10.1097/00005721-200503000-00015. PMID: 15775817.
* Ferrer-Donato A, Contreras A, Frago LM, Chowen JA, Fernandez-Martos CM. Alterations in Leptin Signaling in Amyotrophic Lateral Sclerosis (ALS). Int J Mol Sci. 2021 Sep 24;22(19). doi: 10.3390/ijms221910305. Epub 2021 Sep 24. PMID: 34638645; PMCID: PMC8508891.
* Bhopatkar AA, Dhakal S, Abernathy HG, Morgan SE, Rangachari V. Charge and redox states modulate granulin-TDP-43 coacervation toward phase separation or aggregation. Biophys J. 2022 Jun 7;121(11):2107-2126. doi: 10.1016/j.bpj.2022.04.034. Epub 2022 Apr 30. PMID: 35490297; PMCID: PMC9247478.
* Shen X, Tang C, Wei C, Zhu Y, Xu R. Melatonin Induces Autophagy in Amyotrophic Lateral Sclerosis Mice via Upregulation of SIRT1. Mol Neurobiol. 2022 Aug;59(8):4747-4760. doi: 10.1007/s12035-022-02875-7. Epub 2022 May 23. PMID: 35606613.
* Relyvrio for ALS. Med Lett Drugs Ther. 2022 Nov 28;64(1664):190-191. PMID: 36397190.
* de Majo M, Koontz M, Marsan E, Salinas N, Ramsey A, Kuo YM, Seo K, Li H, Dräger N, Leng K, Gonzales SL, Kurnellas M, Miyaoka Y, Klim JR, Kampmann M, Ward ME, Huang EJ, Ullian EM. Granulin loss of function in human mature brain organoids implicates astrocytes in TDP-43 pathology. Stem Cell Reports. 2023 Mar 14;18(3):706-719. doi: 10.1016/j.stemcr.2023.01.012. Epub 2023 Feb 23. PMID: 36827976; PMCID: PMC10031303.
* Tofersen (Qalsody) for ALS. Med Lett Drugs Ther. 2023 Jul 24;65(1681):113-114. doi: 10.58347/tml.2023.1681a. PMID: 37460141.
* Brown A, Armon C, Barkhaus P, Beauchamp M, Bertorini T, Bromberg M, Cadavid JM, Carter GT, Crayle J, Feldman EL, Heiman-Patterson T, Jhooty S, Linares A, Li X, Mallon E, Mcdermott C, Mushannen T, Nathaniel G, Pattee G, Pierce K, Ratner D, Slactova L, Wicks P, Bedlack R. ALSUntangled #72: Insulin. Amyotroph Lateral Scler Frontotemporal Degener. 2024 May;25(3-4):416-419. doi: 10.1080/21678421.2023.2288110. Epub 2023 Nov 28. PMID: 38018119.
* Lang C, Guillot SJ, Lule D, Balz LT, Knehr A, Weydt P, Dorst J, Kandler K, Muller HP, Kassubek J, Wassermann L, Da Cruz S, Roselli F, Ludolph AC, Bolborea M, Dupuis L. Early brain-wide disruption of sleep microarchitecture in amyotrophic lateral sclerosis. J Clin Invest. 2026 Jan 2;136(1). doi: 10.1172/JCI194555. Epub 2025 Nov 6. PMID: 41196652; PMCID: PMC12721911.
* Goutman SA, Stouffer DG, Jang DG, Park J, Murdock BJ, Auchus RJ. Sex Hormones Associate With Amyotrophic Lateral Sclerosis Risk and Survival. Ann Clin Transl Neurol. 2026 Mar;13(3):612-617. doi: 10.1002/acn3.70281. Epub 2025 Dec 18. PMID: 41412960; PMCID: PMC12968447.
We would love to help them too.
For First Time Users
We provide a database of explanations from real doctors on a range of medical topics. Get started by exploring our library of questions and topics you want to learn more about.
Was this page helpful?
Purpose and positioning of servicesUbie Doctor's Note is a service for informational purposes. The provision of information by physicians, medical professionals, etc. is not a medical treatment. If medical treatment is required, please consult your doctor or medical institution. We strive to provide reliable and accurate information, but we do not guarantee the completeness of the content. If you find any errors in the information, please contact us.